Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
Authors:
- Ting-Yuan LanTLTing-Yuan Lan
- Yen-Chun LinYLYen-Chun Lin
- Tai-Chung TsengTTTai-Chung Tseng
- Hung-Chih YangHYHung-Chih Yang
- Jui-Hung KaoJKJui-Hung Kao
- Chiao-Feng ChengCCChiao-Feng Cheng
- Tai-Ju LeeTLTai-Ju Lee
- Shang-Chin HuangSHShang-Chin Huang
- Cheng-Hsun LuCLCheng-Hsun Lu
- Ko-Jen LiKLKo-Jen Li
- Song-Chou HsiehSHSong-Chou Hsieh
Open Access
- 21 October 2022
- journal article
- research article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 17 (2) , 288-298
Abstract
Ting-Yuan Lan, Yen-Chun Lin, Tai-Chung Tseng, Hung-Chih Yang, Jui-Hung Kao, Chiao-Feng Cheng, Tai-Ju Lee, Shang-Chin Huang, Cheng-Hsun Lu, Ko-Jen Li, and Song-Chou Hsieh. Gut and Liver 2023;17:288-98. https://doi.org/10.5009/gnl210551Keywords
All Related Versions
This publication has 30 references indexed in Scilit:
- Rituximab in the treatment of inflammatory myopathies: a reviewRheumatology, 2016
- Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian StudyThe Journal of Rheumatology, 2016
- Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 YearsThe Journal of Rheumatology, 2015
- Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infectionHepatology, 2015
- American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug TherapyGastroenterology, 2015
- Universal infant immunization and occult hepatitis B virus infection in children and adolescents: A population‐based studyHepatology, 2014
- Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg?Hepatology, 2014
- Rituximab and its therapeutic potential in catastrophic antiphospolipid syndromeTherapeutic Advances in Musculoskeletal Disease, 2014
- Minimization of hepatitis B infection by a 25-year universal vaccination programJournal of Hepatology, 2012
- Occult hepatitis BThe Lancet Infectious Diseases, 2002